Clinical Trial Update: 24-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 Years [Phase 3]

View source ↗

Summary

Phase 3 trial comparing lixisenatide to sitagliptin as add-on therapy to metformin in obese adults with type 2 diabetes; the study is completed and results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lixisenatide (lixisenatide)
• Sitagliptin (sitagliptin)
• metformin (metformin)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2016-10-11